MOHAMMAD RASHEED: Open Payments
NPI 1164400594 · NEVADA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 7 payments from 5 companies in 2025. Trend: 2023 $166 · 2024 $194 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $314 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
Products named: UZEDY, AUSTEDO XR, CAPLYTA, Auvelity, COBENFY, ABILIFY MAINTENA.
Industry payments across MO — which companies pay providers there.
